Blood pressure alterations in burn patients with septic shock under hydro- cortisone treatment
-
Faranak Alinejad
,
Mahnoush Momeni
,
Mohammad Javad Fatemi
,
Mohsen Saberi
,
Mahboobeh Sattar Zade
,
Rafat Babajani
,
Hossein Rahbar
Abstract
Background and Objectives: Hydrocortisone is widely used in septic shock cases resistant to fluid and vasopressor therapy. It may result in increased blood pressure and survival. However the efficacy is no established among patients with severe burn and septic shock. Accordingly it was assessed in this study.
Materials and Methods: The patients older than 14 years of age with resistant septic shock were enrolled during one-year period. The hydrocortisone was prescribed 100 mg three times per day and the alterations in systolic and diastolic blood pressures were recorded.
Results: Twenty-nine patients were enrolled including 19 men and 10 women. The mean age was 37 ± 19 years and the mean burn surface area was 60 ± 20. Fourteen patients had positive blood culture. The most common isolated microorganism were Pseudomonas aeuroginosa in 34.6%(10 cases), and then Acinetobacter in 13.8%(4 cases). The infection was from wound in 79% and the remaining 21% had pneumonia. Twenty-one patients had good response to hydrocortisone and the increase insystolic and diastolic blood pressures was significant; but the mortality rate was similar.
Conclusion: Treatment with hydrocortisone would result in increase in systolic and diastolic blood pressure in burn patients with resistant septic shock.
Mandell GL, Bennett JE, Raphael D (2010). Principles and practice of infectious diseases.7nd Churchill Livingstone/Elsevier.ed. Philadelphia: Churchill Livingstone/Elsevier.
Herndon ND (2012). Total burn care. 4nd York: Saunders Elsevier.ed. New .
Sprung C L, Annane D, Keh D, Moreno R, Sing-er M, Freivogel k,et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008 10;358:111-124.
Shlyk IV, Pivovarova LP, Krylov KM, Filippova OV, Il'ina VA, Krylov PK. Clinical and immunolical cri- teria for burn sepsis. Anesteziol Reanimatol 2005; Jul- Aug: 4:42-45.
Brunicardi FC, Anderson DK, Billiar TR, Dunn DL,Hunter JG, Matthews JB, et all (2014). Schwartz's Principles of Surgery. 10nd Graw-Hill.ed. New York: Mc-
Baudouin V S, editor. Sepsis. London: Springer; 2008.P.1-3.
Khashaba HA1, Al-Fadhli AN, Al-Tarrah KS, Wilson YT, Moiemen N. Epidemiology and outcome of burns at the Saud Al Babtain Burns, Plastic Surgery and Re- constructive Center, Kuwait: our experience over five years (from 2006 to 2010). Ann Burns Fire Disasters 2012;25:178-187.
Karami Matin, Karami Matin R, Ahmadi Joybari T, Ghahvehei N, Haghi M, Ahmadi M, et al. Epidemi- ological data, outcome, and costs of burn patients in Kermanshah. Ann Burns Fire Disasters 2012;25:171-177.
Brusselaers N1, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe: a systematic re- view of the incidence, etiology, morbidity, and mortal- ity. Crit Care 2010;14:R188.
Gupta AK1, Uppal S, Garg R, Gupta A, Pal R. A clini- co-epidemiologic study of 892 patients with burn inju- ries at a tertiary care hospital in Punjab, India. J Emerg Trauma Shock 2011; 4:7-11.
Yavuz A1, Ayse A, Abdullah Y, Belkiz A. Clinical and demographic features of pediatric burns in the eastern provinces of Turkey. Scand J Trauma Resusc Emerg Med 2011; 18:19:6.
Long DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J (2011). Harrison's Principles of Internal Medicine. 18nd ed. New York: McGraw-Hill Medical;Vol. 2, pp.2223-2231.
Wang C, Sun J, Zheng J, Guo L, Ma H, Zhang Y, et al. Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality: a meta-analysis of randomized controlled trials. Anesth Analg 2014;118:346-57.
Sherwin RL1, Garcia AJ, Bilkovski R. Do low dose corticosteroid improve mortality or shock reversal in patients with septic shock? Asystemic review and po- sition statement prepared for the American of Acade- my of Emergency Medicine. J Emerg Med 2012;43:7-12.
Moran JL1, Graham PL, Rockliff S, Bersten AD. Up-dating the evidence for the role of corticosteroids in se- vere sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care 2010; 14:R134.
Fuchs PCh1, Bozkurt A, Johnen D, Smeets R, Groger A, Pallua N. Beneficial effect of corticosteroids in catecholamine-dependent septic burn patients. Burns 2007; May:33:306-311.
| Files | ||
| Issue | Vol 7 No 6 (2015) | |
| Section | Articles | |
| Keywords | ||
| Septic Shock Burn Hydrocortisone | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
